There is a high incidence of psychiatric comorbidities among gender nonconforming teenagers, with about two-thirds and one-third experiencing depression and anxiety, respectively, according to a study presented at ENDO 2020.
Post hoc analyses of the LIBERTY AD SOLO 1 & 2* and ADOL** trials demonstrated significant reductions in pruritus, anxiety, and depression with dupilumab in adults and adolescents with moderate-to-severe atopic dermatitis (AD).
Frontline healthcare workers who are directly diagnosing, treating, or caring for patients with COVID-19 have increased risks for depression, anxiety, insomnia, and distress, according to a study from China.
Delivering twice-weekly sessions of cognitive behavioural therapy (CBT) or interpersonal psychotherapy (IPT) in the treatment of major depressive disorder may lead to better outcomes compared with a weekly session, a study has found.
Major depressive disorder (MDD) patients who do not respond at the second week of treatment with mirtazapine monotherapy, paroxetine monotherapy or their combination appear to show improvements at the eighth week of treatment, according to a study. The data do not support recommendations to routinely offer additional treatment or a switch in treatment strategy to patients who exhibit nonresponse early in the treatment.
Mental disorders and chronic physical conditions represent a serious public health burden in Singapore, with chronic pain, major depressive disorder, obsessive compulsive disorder, cardiovascular disease and generalized anxiety disorder being the top five contributors to increased number of years lived with disability in the general population, according to a recent study.
Routinely used for treating cardiovascular diseases, statins have been shown to benefit other conditions, and new evidence suggests that using the drug at high intensity reduces the risk of hip or knee replacement, an effect that may be specific to rheumatoid arthritis.
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
Pembrolizumab in combination with chemotherapy significantly improves progression-free survival (PFS) vs chemotherapy alone in patients with previously untreated, locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC), results of the KEYNOTE-355 study have shown.